149 Results for "

whole blood

" in MedChemExpress (MCE) Product Catalog:
Products (149)

149 Results for "whole blood" in MCE Product Catalog:

28
28 Publications Verification
Cat. No.: HY-15425
CAS No.: 1415562-82-1
Purity:  99.85%
Synonyms: Sphingosine Kinase 1 Inhibitor II
PF-543 (Sphingosine Kinase 1 Inhibitor II) is a potent, selective, reversible and sphingosine-competitive SPHK1 inhibitor with an IC50 of 2 nM and a Ki of 3.6 nM. PF-543 is >100-fold selectivity for SPHK1 over SPHK2. PF-543 is an effective potent inhibitor of sphingosine 1-phosphate (S1P) formation in whole blood with an IC50 of 26.7 nM. PF-543 induces apoptosis, necrosis, and autophagy .
loading...
    loading...
28
28 Publications Verification
Cat. No.: HY-15425A
CAS No.: 1415562-83-2
Purity:  99.47%
Synonyms: Sphingosine Kinase 1 Inhibitor II Citrate
PF-543 Citrate (Sphingosine Kinase 1 Inhibitor II Citrate) is a potent, selective, reversible and sphingosine-competitive SPHK1 inhibitor with an IC50 of 2 nM and a Ki of 3.6 nM. PF-543 Citrate is >100-fold selectivity for SPHK1 over SPHK2. PF-543 Citrate is an effective potent inhibitor of sphingosine 1-phosphate (S1P) formation in whole blood with an IC50 of 26.7 nM. PF-543 Citrate induces apoptosis, necrosis, and autophagy .
loading...
    loading...
17
17 Cited Publications
Cat. No.: HY-K0311

MCE GSH/GSSG Assay Kit is suitable for the quantitative determination of reduced and oxidized glutathione (GSH/GSSG) in whole blood, plasma, serum, urine, and tissue and cell extracts.

loading...
    loading...
14
14 Cited Publications
Cat. No.: HY-14166
CAS No.: 118414-82-7
Purity:  99.87%
Synonyms: L 663536
Research Areas:  

Cancer

MK-886 (L 663536) is a potent, cell-permeable and orally active FLAP (IC50 of 30 nM) and leukotriene biosynthesis (IC50s of 3 nM and 1.1 μM in intact leukocytes and human whole blood, respectively) inhibitor. MK-886 is also a non-competitive PPARα antagonist and can induce apoptosis .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-B0742
CAS No.: 630-56-8
Synonyms: 17α-Hydroxyprogesterone hexanoate; 17α-Hydroxyprogesterone caproate
Target:  

Progesterone Receptor

Research Areas:  

Endocrinology

Hydroxyprogesterone caproate (17α-Hydroxyprogesterone hexanoate; 17α-Hydroxyprogesterone caproate) is a progesterone receptor (progesterone receptor) ligand and steroid hormone transcription inhibitor. Hydroxyprogesterone caproate downregulates estrogen receptors in target tissues and activates their metabolic pathways, and exhibits equivalent affinity for progesterone receptor A and progesterone receptor B. Hydroxyprogesterone caproate shows no consistent teratogenicity or developmental toxicity in rat, mouse and monkey models, but induces resorption or abortion in rhesus monkeys at human-equivalent doses. Hydroxyprogesterone caproate promotes the production of TNF-α in lipopolysaccharide-stimulated whole blood from non-pregnant women. Hydroxyprogesterone caproate can be used in scientific research related to preterm birth .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-13344
CAS No.: 1144035-53-9
Purity:  99.05%
Research Areas:  

Inflammation/Immunology Cancer

PF-8380 is a potent autotaxin inhibitor with an IC50 of 2.8 nM in isolated enzyme assay and 101 nM in human whole blood.
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-13344A
CAS No.: 2070015-01-7
Purity:  98.59%
Research Areas:  

Inflammation/Immunology Cancer

PF-8380 hydrochloride is a potent autotaxin inhibitor with an IC50 of 2.8 nM in isolated enzyme assay and 101 nM in human whole blood.
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-10797
CAS No.: 847728-01-2
Purity:  98.84%
Synonyms: CJ-042794
CJ-42794 (CJ-042794) is a potent, orally active, selective prostaglandin E receptor 4 (EP4) antagonist with an IC50 value of 10 nM, which is 200-fold more selective than EP1, EP2 and EP3. CJ-42794 can be used in research of gastric ulcers .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-B2209
CAS No.: 13422-51-0
Synonyms: Vitamin B12a
Hydroxocobalamin (Vitamin B12a) is a cyanide antidote. Hydroxocobalamin can decrease the cell and plasma cyanide concentrations and increase survival rate in acute cyanide poisoning. Hydroxocobalamin can improve newborn Cbl-C defect-induced metabolic profile and neurocognitive outcome. Hydroxocobalamin can normalize Vitamin B12 deficiency. Hydroxocobalamin can induce acute kidney injury. Hydroxocobalamin can be used for the researches of metabolic and neurological disease .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-B0883
CAS No.: 1811-28-5
3,6-Diaminoacridine hemisulfate is a multifunctional acridine compound. 3,6-Diaminoacridine hemisulfate is an acridine dye and also a DNA inserter. 3,6-Diaminoacridine hemisulfate is a potent broad-spectrum antibacterial agent. Its mechanism is to insert into bacterial DNA, interfering with replication and transcription, leading to bacterial lysis. 3,6-Diaminoacridine hemisulfate is a Kir3.2 potassium channel blocker and can be used to study the neurological phenotype of Down syndrome. 3,6-Diaminoacridine hemisulfate can penetrate the stratum corneum of the skin and accumulate in the cell nucleus. Long-term exposure may induce skin cancer or other malignant tumors .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-32018
CAS No.: 915363-56-3
Target:  

MAP3K

Research Areas:  

Cancer

Cot inhibitor-2 is a potent, selective and orally active cot (Tpl2/MAP3K8) inhibitor with an IC50 of 1.6 nM. Cot inhibitor-2 inhibts TNF-α production in LPS-stimulated human whole blood with an IC50 of 0.3 μM .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-32015
CAS No.: 915365-57-0
Target:  

MAP3K

Research Areas:  

Inflammation/Immunology

Cot inhibitor-1 (compound 28) is a selective tumor progression loci-2 (Tpl2) kinase inhibitor with an IC50 of 28 nM. Cot inhibitor-1 shows an inhibition of TNF-alpha production in human whole blood with an IC50 of 5.7 nM .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-102064
CAS No.: 77145-61-0
Purity:  99.86%
Target:  

5-HT Receptor

Research Areas:  

Neurological Disease

SR 57227A is a potent, orally active and selective 5-HT3 receptor agonist, with ability to cross the blood brain barrier. SR 57227A has affinities (IC50) varying between 2.8 and 250 nM for 5-HT3 receptor binding sites in rat cortical membranes and on whole NG 108-15 cells or their membranes. Anti-depressant effects .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-15321
CAS No.: 202409-33-4
Purity:  99.86%
Synonyms: MK-0663; L-791456
Target:  

COX

Research Areas:  

Inflammation/Immunology Cancer

Etoricoxib (MK-0663) is a non steroidal anti-inflammatory agent, acting as a selective and orally active COX-2 inhibitor. Etoricoxib can cross the blood-brain barrier, with IC50s of 1.1 μM and 116 μM for COX-2 and COX-1 in human whole blood .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-150508
CAS No.: 2641484-61-7
Purity:  98.60%
MK-0159 is an orally active, potent and selective CD38 inhibitor, with IC50 values of 22, 3, and 70 nM for human, mouse and rat CD38, respectively. MK-0159 also shows good microsomal stability for human and rodent liver microsomes. MK-0159 increases NAD + (nicotinamide adenine dinucleotide) and reduces ADPR (adenosine diphosphate ribose) in whole blood and heart .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-137892
CAS No.: 2088410-46-0
Purity:  99.79%
Research Areas:  

Inflammation/Immunology

GSK620, a chemical probe, is a potent and orally active pan-BD2 inhibitor with excellent broad selectivity, developability and in vivo oral pharmacokinetics. GSK620 is highly selective for the BET-BD2 family of proteins, with >200-fold selectivity over all other bromodomains. GSK620 shows an anti-inflammatory phenotype in human whole blood .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-120878
CAS No.: 1838123-21-9
Purity:  99.52%
Target:  

CXCR

Research Areas:  

Inflammation/Immunology

CXCR2-IN-2 is a selective, brain penetrant, and orally bioavailable CXCR2 antagonist (IC50=5.2 nM/1 nM in β-arrestin assay/CXCR2 Tango assay, respectively). CXCR2-IN-2 displays ~730-fold selectivity over CXCR1 and >1900-fold selectivity over all other chemokine receptors. CXCR2-IN-2 inhibits human whole blood Gro-α induced CD11b expression with an IC50 of 0.04 μM .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-113854
CAS No.: 1034148-15-6
Purity:  99.90%
AZD2906 is a selective glucocorticoid receptor (GR) agonist, increases micronucleated immature erythrocytes in the bone marrow of rats. AZD2906 shows IC50s of 2.2, 0.3, 41.6 and 7.5 nM at GR in human, rat PBMC and human, rat whole blood, respectively .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-135674
CAS No.: 2413286-32-3
Purity:  99.89%
Target:  

p38 MAPK TNF Receptor

Research Areas:  

Inflammation/Immunology Cancer

SR-318, a chemical probe, is a potent and highly selective p38 MAPK inhibitor with IC50s of 5 nM, 32 nM and 6.11 μM for p38α, p38β and p38α/β, respectively. SR-318 potently inhibits the TNF-α release in whole blood with an IC50 of 283 nM. SR-318 has anti-cancer and anti-inflammatory activity .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-153254
CAS No.: 2205846-49-5
Purity:  99.59%
Research Areas:  

Inflammation/Immunology

BMS905 is an orally active TLR7 and TLR8 dual inhibitor (IC50s: 0.7 and 3.2 nM respectively). BMS905 inhibits TLR7 or TLR8 induced IL-6 production in human/mouse whole blood. BMS905 can be used for research of lupus .
loading...
    loading...